MCP-1 and soluble IL-2Rα were moderate predictors of the need for hospitalization in a cohort of patients with various disease severities in a study which identified elevated IL-6 as best predictor of severity of COVID-19 (1). This evidence concerns the gene IL6 and COVID-19.